https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
INTRODUCTION Breast cancer (BC) is a heterogenous disease and a major public health burden in Bahrain. Based on hormone receptor status (ER, PR, and HER2), BC can be divided into four molecular subtypes Luminal A, Luminal B, HER2+, and Triple negative, each of which display distinct clinical behaviour. PATIENTS AND METHODS This retrospective study included 216 patients diagnosed with BC between November 2017 and May 2019 at the Bahrain oncology centre. The clinicopathological characteristics (age, size of tumour, grade
Beğen
Yorum Yap
Paylaş
